The Image Guided Radiotherapy Market is experiencing continued development as radiation oncology moves toward more precise and technology-supported treatment methods. Image-guided systems help healthcare professionals visualize relevant anatomy during different stages of radiotherapy, supporting tumor targeting, treatment planning, and verification.

One of the key factors supporting market demand is the increasing incidence of cancer worldwide. As more patients require radiation-based treatment, healthcare systems are looking for technologies that can improve treatment workflows and support accurate radiation delivery.

Artificial intelligence is also creating new opportunities. AI-assisted software can support activities such as image analysis, treatment planning, and automated contouring. In June 2026, GE HealthCare received U.S. FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, an AI-enabled auto-contouring software intended to assist radiation oncology teams with treatment planning.

Research collaborations are another part of the industry's development. In May 2026, Accuray and the University of Wisconsin School of Medicine and Public Health announced a 10-year strategic collaboration focused on personalized cancer treatment using Accuray's Stellar adaptive radiation therapy platform.

These developments demonstrate how imaging, software, artificial intelligence, and adaptive radiotherapy are becoming increasingly connected. Continued innovation in these areas could support the expansion of image-guided radiotherapy across oncology facilities.

Explore key developments shaping industry transformation:

Bioinformatics Market Trends

Dental Consumables Market Growth

Mesenchymal Stem Cells Market Demand

Dental 3D Printing Market Volume

Healthcare Cyber Security Market Forecast